A carregar...
Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
Ticagrelor (TGL), a P2Y(12) receptor antagonist, is classified as biopharmaceutics classification system (BCS) class IV drug due to its poor solubility and permeability, resulting in low oral bioavailability. Nanostructured lipid carriers (NLC) are an efficient delivery system for the improvement of...
Na minha lista:
| Publicado no: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6572397/ https://ncbi.nlm.nih.gov/pubmed/31071977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11050222 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|